Bio-Techne · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← TECH

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q4	2026-06-30	0.32	+1.3%	65.8%	0.07	—	—	0.09	0.36	0.04	0.01
FY2026 Q3	2026-03-31	0.31	−1.5%	66.9%	0.08	0.05	16.4%	0.08	0.32	0.00	0.01
FY2026 Q2	2025-12-31	0.30	−0.4%	64.6%	0.05	0.04	12.8%	0.08	0.24	0.00	0.01
FY2026 Q1	2025-09-30	0.29	−1.0%	65.6%	0.05	0.04	13.3%	0.02	0.24	0.00	0.01
FY2025 Q4	2025-06-30	0.32	+3.5%	62.7%	-0.02	-0.02	-5.6%	0.09	-0.11	0.10	0.01
FY2025 Q3	2025-03-31	0.32	+4.2%	67.9%	0.04	0.02	7.1%	0.03	0.14	0.10	0.01
FY2025 Q2	2024-12-31	0.30	+9.0%	65.3%	0.05	0.03	11.7%	0.08	0.22	—	0.01
FY2025 Q1	2024-09-30	0.29	+4.5%	63.2%	0.04	0.03	11.6%	0.05	0.21	—	0.01
FY2024 Q4	2024-06-30	0.31	+1.6%	66.4%	0.05	0.04	13.3%	0.06	0.26	0.00	0.01
FY2024 Q3	2024-03-31	0.30	+3.2%	67.4%	0.07	0.05	16.2%	0.06	0.31	0.00	0.01
FY2024 Q2	2023-12-31	0.27	+0.4%	64.8%	0.04	0.03	10.1%	0.07	0.17	—	0.01
FY2024 Q1	2023-09-30	0.28	+2.7%	66.9%	0.06	0.05	18.4%	0.05	0.31	—	0.01
FY2023 Q4	2023-06-30	0.30	—	67.9%	0.09	0.08	25.1%	0.07	0.47	0.00	0.01
FY2023 Q3	2023-03-31	0.29	—	68.7%	0.08	0.07	23.9%	0.04	0.43	0.00	0.01
FY2023 Q2	2022-12-31	0.27	—	67.5%	0.07	0.05	18.4%	0.06	0.31	0.00	0.01
FY2023 Q1	2022-09-30	0.27	—	66.6%	0.06	0.09	33.2%	0.05	0.55	0.02	0.01

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.